Genenta & Anemocyte ink partnership to advance off-the-shelf LVV Plasmid DNA production: Milan Monday, October 27, 2025, 14:00 Hrs [IST] Genenta Science, a pioneer company in immu ...

Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.

A new way to deliver protective antibodies against COVID-19 was tested in a Phase I clinical trial. Instead of injecting ...

Elegen, a global leader in next-generation cell-free DNA manufacturing, today announced the early access launch of ...

Monday that a global tier-one pharmaceutical partner had started dosing patients in a phase one and two US clinical trial ...

Genenta Science (NasdaqCM:GNTA) recently drew widespread attention after announcing an expanded partnership with Anemocyte, centered on advancing off-the-shelf lentiviral vector Plasmid DNA technology ...

Once upon a time, everyone wanted to give us their own take on Rapture. Here are six games that tried to be the next BioShock ...

Investing.com -- 4basebio PLC (AIM:4BB) stock surged 6.9% on Monday after announcing that a global Tier 1 pharmaceutical partner has begun dosing patients in Phase I/II clinical trials using the ...

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds to the Company from the ...

The partner firm has used 4basebio's template to develop an mRNA product which has been tested on patients in phase-one and two clinical trials, following investigational new drug approval from the US ...

The U.S. IND CDMO market offers growth via extensive pipelines in oncology and rare diseases, driven by technological advancements, outsourcing trends, regulatory efficiencies, and modular GMP ...

Participants received intramuscular injections of synthetic DNA plasmids encoding AstraZeneca’s monoclonal antibodies AZD5396 ...